In the Interest of Balance: A Clarification of My Recent FOB Post

In my post on FOB legislation I pointed out that the work of economist Alex Brill was supported by generic company Teva. A reader has correctly pointed out that Henry Grabowski's work was partially funded by the Pharmaceutical Research and Manufacturer's of America (PhRMA), a group representing innovators, and I have revised the post to note this.